Banque Pictet & Cie Sa Exact Sciences Corp Transaction History
Banque Pictet & Cie Sa
- $14.9 Billion
- Q4 2024
A detailed history of Banque Pictet & Cie Sa transactions in Exact Sciences Corp stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 70,693 shares of EXAS stock, worth $3.33 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
70,693
Previous 189,233
62.64%
Holding current value
$3.33 Million
Previous $12.9 Million
69.17%
% of portfolio
0.03%
Previous 0.1%
Shares
21 transactions
Others Institutions Holding EXAS
# of Institutions
672Shares Held
164MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$825 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$801 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$568 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$567 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$293 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.33B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...